Katti Jessen

Title: **Katti Jessen: Innovator in Cancer Therapeutics**

Introduction

Katti Jessen is a prominent inventor based in San Diego, California, renowned for his contributions to biomedical innovation. With a focus on developing novel therapies, Jessen's research and inventions aim to address critical challenges in treating cancers.

Latest Patents

Katti Jessen holds a patent for ROR1 antibody immunoconjugates. This innovative patent encompasses immunoconjugates that include an anti-ROR1 antibody or antigen-fragment and a drug moiety. These immunoconjugates show great promise in the treatment of ROR1 expressing cancers, potentially providing new avenues for patient care.

Career Highlights

Currently, Jessen works with VelosBio Inc., a leading biopharmaceutical company focused on developing targeted therapies for cancer. His role within the organization underscores his commitment to advancing cancer research and therapeutic solutions.

Collaborations

Throughout his career, Katti Jessen has collaborated with talented professionals, including Brian Lannutti and Thanh-Trang Vo. These partnerships highlight the collaborative nature of scientific research, fostering innovation and the development of effective therapies.

Conclusion

In summary, Katti Jessen's contributions to the field of cancer therapeutics through his patent on ROR1 antibody immunoconjugates demonstrate his expertise and innovative spirit. As he continues to work with VelosBio Inc. and collaborate with fellow scientists, the impact of his inventions will likely resonate in the biomedical field for years to come.